# Verde Clean Fuels, Inc.: overview VGAS · Nasdaq · CIK 1841425 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/vgas.md) · [Financials](/companies/vgas/financials.md) · [Filings](/companies/vgas/filings.md) · [Insiders](/companies/vgas/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | [(0.08)](/filings/0001628280-26-033746.md) | [(0.07)](/filings/0001628280-26-055390.md) | not reported | not reported | [(0.05)](/filings/0001628280-26-033746.md) | [(0.04)](/filings/0001628280-26-055390.md) | | Free cash flow | $k | [(2,531) d](/filings/0001628280-25-052351.md) | [(3,330) d](/filings/0001628280-26-021763.md) | [(4,175)](/filings/0001628280-26-033746.md) | [(3,728) d](/filings/0001628280-26-055390.md) | [(4,118) d](/filings/0001628280-25-052351.md) | [(4,553) d](/filings/0001628280-26-021763.md) | [(3,075)](/filings/0001628280-26-033746.md) | [(827) d](/filings/0001628280-26-055390.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.05)](/filings/0001213900-22-015914.md) | not reported | [(0.45)](/filings/0001628280-25-015480.md) | [(0.53)](/filings/0001628280-25-015480.md) | not reported | | Free cash flow | $m | not reported | [(3.3)](/filings/0001213900-24-027258.md) | [(9.2)](/filings/0001628280-25-015480.md) | [(11.4)](/filings/0001628280-26-021763.md) | [(16.6)](/filings/0001628280-26-021763.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vgas/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Bluescape Energy Partners LLC](/funds/1629283.md) | 2026-06-30 | $816.0k | 800,000 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $125.0k | 122,540 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $44.7k | 43,825 | | Reduced −61,382 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $38.0k | 37,259 | | Added +16,559 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $33.0k | 32,401 | | New +32,401 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $29.0k | 28,387 | | Reduced −130,726 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $27.9k | 27,357 | | Added +21,467 | | [ARISTEIA CAPITAL, L.L.C.](/funds/1080171.md) | 2026-06-30 | $25.3k | 932,090 | | Unchanged | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $23.8k | 23,353 | | New +23,353 | | [Carlson Capital, L.P.](/funds/1056973.md) | 2026-06-30 | $20.4k | 20,000 | | New +20,000 | ## Recent filings [All 243 filings](/companies/vgas/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 17:39 ET | [10-Q](/filings/0001628280-26-055390.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055390 | | 2026-08-11 | 17:36 ET | [8-K](/filings/0001628280-26-055381.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055381 | | 2026-06-15 | 16:11 ET | [8-K](/filings/0001628280-26-043180.md) | 5.07 Shareholder vote results | 0001628280-26-043180 | | 2026-06-09 | 16:10 ET | [8-K](/filings/0001628280-26-041891.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-041891 | | 2026-05-12 | 18:53 ET | [10-Q](/filings/0001628280-26-033746.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033746 | | 2026-05-12 | 18:42 ET | [8-K](/filings/0001628280-26-033741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033741 | | 2026-04-28 | 08:11 ET | [DEF 14A](/filings/0001628280-26-027734.md) | Proxy statement, period 2026-04-28 | 0001628280-26-027734 | | 2026-03-27 | 16:48 ET | [10-K](/filings/0001628280-26-021763.md) | Annual report, period 2025-12-31 | 0001628280-26-021763 | | 2026-03-27 | 16:41 ET | [8-K](/filings/0001628280-26-021761.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021761 | | 2026-03-23 | 18:33 ET | [8-K](/filings/0001628280-26-020270.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-020270 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-021763.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1841425 - Tickers: VGAS, VGASW - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.